MCID: ADL048
MIFTS: 11

Adult Malignant Hemangiopericytoma

Categories: Cancer diseases, Rare diseases

Aliases & Classifications for Adult Malignant Hemangiopericytoma

MalaCards integrated aliases for Adult Malignant Hemangiopericytoma:

Name: Adult Malignant Hemangiopericytoma 12 72

Classifications:



External Ids:

Disease Ontology 12 DOID:6332
NCIt 50 C7946
UMLS 72 C0279547

Summaries for Adult Malignant Hemangiopericytoma

MalaCards based summary : Adult Malignant Hemangiopericytoma The drugs Ifosfamide and Mechlorethamine have been mentioned in the context of this disorder. Affiliated tissues include lung and bone.

Related Diseases for Adult Malignant Hemangiopericytoma

Diseases in the Hemangiopericytoma, Malignant family:

Adult Malignant Hemangiopericytoma

Symptoms & Phenotypes for Adult Malignant Hemangiopericytoma

Drugs & Therapeutics for Adult Malignant Hemangiopericytoma

Drugs for Adult Malignant Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ifosfamide Approved Phase 3 3778-73-2 3690
2
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
3
Lenograstim Approved, Investigational Phase 3 135968-09-1
4
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
5
Doxorubicin Approved, Investigational Phase 2, Phase 3 23214-92-8 31703
6
Isophosphamide mustard Phase 3 0
7 Alkylating Agents Phase 2, Phase 3
8 Antineoplastic Agents, Alkylating Phase 2, Phase 3
9 Topoisomerase Inhibitors Phase 2, Phase 3
10
Liposomal doxorubicin Phase 2, Phase 3 31703
11 Anti-Bacterial Agents Phase 2, Phase 3
12 Antibiotics, Antitubercular Phase 2, Phase 3
13
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
14
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
15
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
16
Vatalanib Investigational Phase 2 212141-54-3 151194
17 Exatecan Investigational Phase 2 171335-80-1
18
Camptothecin Experimental Phase 2 7689-03-4
19 Soblidotin Investigational Phase 2 149606-27-9
20 Protein Kinase Inhibitors Phase 2
21 Antineoplastic Agents, Phytogenic Phase 2
22 topoisomerase I inhibitors Phase 2
23 Angiogenesis Inhibitors Phase 2
24 Angiogenesis Modulating Agents Phase 2
25 Immunosuppressive Agents Phase 2
26 Imatinib Mesylate Phase 1, Phase 2 220127-57-1 123596
27
Celecoxib Approved, Investigational Phase 1 169590-42-5 2662
28 Analgesics Phase 1
29 Anti-Inflammatory Agents Phase 1
30 Analgesics, Non-Narcotic Phase 1
31 Cyclooxygenase Inhibitors Phase 1
32 Cyclooxygenase 2 Inhibitors Phase 1
33 Peripheral Nervous System Agents Phase 1
34 Anti-Inflammatory Agents, Non-Steroidal Phase 1
35 Antirheumatic Agents Phase 1

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Randomised Trial of Post-Operative Radiotherapy Given to Adult Patients With Extremity Soft Tissue Sarcoma [VORTEX] Completed NCT00423618 Phase 3
2 Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
3 METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP) Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
4 RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
5 TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
6 Phase II Evaluation of Temodal (Temozolomide, Schering) in Previously Treated Advanced Sarcomas Unknown status NCT00003718 Phase 2 temozolomide
7 A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas Completed NCT00348790 Phase 2 vatalanib
8 Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult Completed NCT00003939 Phase 2 trabectedin
9 Exatecan As Second-Line Treatment In Advanced Adult Soft Tissue Sarcoma: A Phase II - Study Of The EORTC Soft Tissue And Bone Sarcoma Group Completed NCT00041236 Phase 2 exatecan mesylate
10 Phase II Trial of BAY-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2 sorafenib
11 A Phase II Study of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, to Patients With Advanced or Metastatic Soft Tissue Sarcomas (STS) With Prior Exposure to Anthracycline-Based Chemotherapy Completed NCT00064220 Phase 2 soblidotin
12 A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
13 Efficacy And Safety Study Of Brostallicin In Patients With Locally Advanced Or Metastatic Soft Tissue Sarcoma Failing One Prior Chemotherapy Treatment Completed NCT00041249 Phase 2 brostallicin
14 A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
15 Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
16 Phase II Study of Preoperative Intensity-Modulated Radiation Therapy for Soft-Tissue Sarcomas Terminated NCT00740597 Phase 2
17 Phase I Study To Determine The Safety Of Caelyx (Doxorubin HCI, Pegylated Liposomal) In Combination With Ifosfamide In Previously Untreated Adult Patients With Advanced And/Or Metastatic Soft Tissues Sarcomas Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
18 A Phase I Trial of Postoperative Radiation With Dose-Escalation of A Cox-2 Inhibitor, Celebrex™ (CELECOXIB) in Patients With Soft Tissue Sarcoma of the Extremity Completed NCT00450736 Phase 1 celecoxib
19 VORTEX-BIOBANK: Prospective Sample Collection for the VORTEX Randomised Radiotherapy Trial in Patients With Extremity Soft Tissue Sarcoma [VORTEX BIOBANK] Unknown status NCT00900211

Search NIH Clinical Center for Adult Malignant Hemangiopericytoma

Genetic Tests for Adult Malignant Hemangiopericytoma

Anatomical Context for Adult Malignant Hemangiopericytoma

MalaCards organs/tissues related to Adult Malignant Hemangiopericytoma:

41
Lung, Bone

Publications for Adult Malignant Hemangiopericytoma

Variations for Adult Malignant Hemangiopericytoma

Expression for Adult Malignant Hemangiopericytoma

Search GEO for disease gene expression data for Adult Malignant Hemangiopericytoma.

Pathways for Adult Malignant Hemangiopericytoma

GO Terms for Adult Malignant Hemangiopericytoma

Sources for Adult Malignant Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....